Abstract
Novel phenomena, such as constitutive activity and inverse agonism, have led to a ligand (re)classification along an agonists-neutral antagonist-inverse agonist continuum. This review focuses on adenosine A1 receptor ligands and their intrinsic activity (α). The intrinsic activity of a ligand depends both on the chemical characteristics of the compound itself and on the experimental conditions in which it is assayed. Consequently, due to this tissue-dependency determination of a ligands intrinsic activity is not always easily performed. Meanwhile, this feature may also be used in a profitable manner, namely to separate desired and unwanted effects of the drug. Briefly, this review provides possible screening methods to distinguish the different classes of ligands. It also deals with the structural elements and functional groups in the adenosine A1 receptor ligands that determine their intrinsic activity.
Keywords: adenosine receptor, inverse agonism, a1 receptor, intrinsic activity, partial agonism
Current Pharmaceutical Design
Title: Intrinsic Activity at Adenosine A1 Receptors: Partial and Inverse Agonism
Volume: 8 Issue: 26
Author(s): Rianne A.F. de Ligt and Ad P. Ijzerman
Affiliation:
Keywords: adenosine receptor, inverse agonism, a1 receptor, intrinsic activity, partial agonism
Abstract: Novel phenomena, such as constitutive activity and inverse agonism, have led to a ligand (re)classification along an agonists-neutral antagonist-inverse agonist continuum. This review focuses on adenosine A1 receptor ligands and their intrinsic activity (α). The intrinsic activity of a ligand depends both on the chemical characteristics of the compound itself and on the experimental conditions in which it is assayed. Consequently, due to this tissue-dependency determination of a ligands intrinsic activity is not always easily performed. Meanwhile, this feature may also be used in a profitable manner, namely to separate desired and unwanted effects of the drug. Briefly, this review provides possible screening methods to distinguish the different classes of ligands. It also deals with the structural elements and functional groups in the adenosine A1 receptor ligands that determine their intrinsic activity.
Export Options
About this article
Cite this article as:
de Ligt A.F. Rianne and Ijzerman Ad P., Intrinsic Activity at Adenosine A1 Receptors: Partial and Inverse Agonism, Current Pharmaceutical Design 2002; 8 (26) . https://dx.doi.org/10.2174/1381612023392874
DOI https://dx.doi.org/10.2174/1381612023392874 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Synthesis of 3,4–Dihydropyrimidin–2-ones (DHPMs) Using Highly Efficient Recyclable Silica Supported Rhodium Chloride as Heterogeneous Catalyst and their Anti-Neuroinflammatory Activity
Letters in Drug Design & Discovery Mass Spectrometry in High Throughput Screening: A Case Study on Acetyl-Coenzyme A Carboxylase using RapidFire® – Mass Spectrometry (RF-MS)
Combinatorial Chemistry & High Throughput Screening The HIV Life Cycle: Multiple Targets for Antiretroviral Agents
Drug Design Reviews - Online (Discontinued) One Special Question to Start with: Can HIF/NFkB be a Target in Inflammation?
Endocrine, Metabolic & Immune Disorders - Drug Targets Protein Phosphatase 2A as a Potential Target for Treatment of Adult T Cell Leukemia
Current Cancer Drug Targets Islet Inflammation in Type 2 Diabetes (T2D): From Endothelial to β-Cell Dysfunction
Current Immunology Reviews (Discontinued) TGF-b: A Fibrotic Factor in Wound Scarring and a Potential Target for Anti- Scarring Gene Therapy
Current Gene Therapy Autoimmunity-Inducing Metals (Hg, Au and Ag) Modulate Mast Cell Signaling, Function and Survival
Current Pharmaceutical Design Cyclooxygenase as a Target for Colorectal Cancer Chemoprevention
Current Drug Targets Cholesterol and Apoe: A Target for Alzheimers Disease Therapeutics
Current Drug Targets - CNS & Neurological Disorders Algae Polysaccharides’ Chemical Characterization and their Role in the Inflammatory Process
Current Medicinal Chemistry In vitro Effects of Polyphenols on the Peripheral Immune Responses in Nickel-sensitized Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets Diet and the Anti-inflammatory Effect of Heat Shock Proteins
Endocrine, Metabolic & Immune Disorders - Drug Targets Regulation of Myometrial Smooth Muscle Functions
Current Pharmaceutical Design Telomere End Protection in Stem Cells and Cancer Cells
Current Cancer Therapy Reviews Resveratrol, a Phytochemical Inducer of Multiple Cell Death Pathways: Apoptosis, Autophagy and Mitotic Catastrophe
Current Medicinal Chemistry Diabetes-Induced Alterations in Renal Medullary Microcirculation and Metabolism
Current Diabetes Reviews Patents in Targets and Drugs for Unbalanced Cytokine and Chemokine Network Mediated Disorders
Recent Patents on Inflammation & Allergy Drug Discovery In-vitro Characterization of Chitosan Nanoparticles of Fluconazole as a Carrier for Sustained Ocular Delivery
Nanoscience & Nanotechnology-Asia Dietary Approaches to Attain Fish Health with Special Reference to their Immune System
Current Pharmaceutical Design